Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Clinicopathologic characteristics of interval gastric cancer in Korea.

Park MS, Yoon JY, Chung HS, Lee H, Park JC, Shin SK, Lee SK, Lee YC.

Gut Liver. 2015 Mar;9(2):166-73. doi: 10.5009/gnl13425.

2.

Missed esophageal and gastric cancers after esophagogastroduodenoscopy in a midwestern military veteran population.

Khalil Q, Gopalswamy N, Agrawal S.

South Med J. 2014 Apr;107(4):225-8. doi: 10.1097/SMJ.0000000000000092.

PMID:
24937515
3.

Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees.

Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, Lee JS, Park SR, Lee JH, Ryu KW, Kim YW.

Eur J Gastroenterol Hepatol. 2009 Aug;21(8):855-60. doi: 10.1097/MEG.0b013e328318ed42.

PMID:
19369882
4.

Low prevalence of microsatellite instability in interval gastric cancers.

Choi HS, Lee SY, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ, Han HS.

Dig Dis Sci. 2014 Feb;59(2):322-7. doi: 10.1007/s10620-013-2987-0. Epub 2013 Dec 20.

PMID:
24357187
5.

Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea.

Lim SB, Jeong SY, Choi HS, Sohn DK, Hong CW, Jung KH, Chang HJ, Park JG, Choi IJ, Kim CG.

Int J Colorectal Dis. 2008 Jan;23(1):61-5. Epub 2007 Aug 28.

PMID:
17724601
6.

Risk factors of developing interval early gastric cancer after negative endoscopy.

Cho YS, Chung IK, Kim JH, Jung Y, Lee TH, Park SH, Kim SJ.

Dig Dis Sci. 2015 Apr;60(4):936-43. doi: 10.1007/s10620-014-3384-z. Epub 2014 Oct 15.

PMID:
25316551
7.

Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening.

Park CH, Kim B, Chung H, Lee H, Park JC, Shin SK, Lee SK, Lee YC.

Dig Dis Sci. 2015 Jan;60(1):38-46. doi: 10.1007/s10620-014-3288-y. Epub 2014 Jul 26.

PMID:
25063206
8.

How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas?

Yoo JH, Shin SJ, Lee KM, Choi JM, Wi JO, Kim DH, Lim SG, Hwang JC, Cheong JY, Yoo BM, Lee KJ, Kim JH, Cho SW.

J Clin Gastroenterol. 2013 Feb;47(2):e17-22. doi: 10.1097/MCG.0b013e31825c0b69.

PMID:
22810109
9.

The optimal endoscopic screening interval for detecting early gastric neoplasms.

Park CH, Kim EH, Chung H, Lee H, Park JC, Shin SK, Lee YC, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim CB, Lee SK.

Gastrointest Endosc. 2014 Aug;80(2):253-9. doi: 10.1016/j.gie.2014.01.030. Epub 2014 Mar 6.

PMID:
24613579
10.

A cohort study of missed and new cancers after esophagogastroduodenoscopy.

Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF.

Am J Gastroenterol. 2010 Jun;105(6):1292-7. doi: 10.1038/ajg.2009.736. Epub 2010 Jan 12.

PMID:
20068557
11.

Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study.

Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY.

Gastrointest Endosc. 2009 Jun;69(7):1228-35. doi: 10.1016/j.gie.2008.09.027. Epub 2009 Feb 27.

PMID:
19249769
12.

Gastric Cancers Missed During Endoscopy in England.

Chadwick G, Groene O, Riley S, Hardwick R, Crosby T, Hoare J, Hanna GB, Greenaway K, Cromwell DA.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1264-1270.e1. doi: 10.1016/j.cgh.2015.01.025. Epub 2015 Jan 30.

PMID:
25645877
13.

Rate and Predictors of Interval Esophageal and Gastric Cancers after Esophagogastroduodenoscopy in the United States.

Wang YR, Loftus EV Jr, Judge TA, Peikin SR.

Digestion. 2016;94(3):176-180. doi: 10.1159/000452794. Epub 2016 Nov 22.

PMID:
27871069
14.
15.

Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea.

Chung SJ, Park MJ, Kang SJ, Kang HY, Chung GE, Kim SG, Jung HC.

Int J Cancer. 2012 Nov 15;131(10):2376-84. doi: 10.1002/ijc.27501. Epub 2012 Apr 16.

16.

Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy.

Teh JL, Tan JR, Lau LJ, Saxena N, Salim A, Tay A, Shabbir A, Chung S, Hartman M, So JB.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):480-487.e2. doi: 10.1016/j.cgh.2014.07.059. Epub 2014 Aug 10.

PMID:
25117772
17.

Does the interval of screening endoscopy affect survival in gastric cancer patients?: A cross-sectional study.

Kim J, Kim SM, Ha MH, Seo JE, Choi MG, Lee JH, Sohn TS, Kim S, Jung SH, Bae JM.

Medicine (Baltimore). 2016 Dec;95(49):e5490.

18.
19.

The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan.

Kobayashi D, Takahashi O, Arioka H, Fukui T.

BMC Gastroenterol. 2012 Oct 17;12:144. doi: 10.1186/1471-230X-12-144.

20.

Survival outcome associated with the screening interval for gastric cancer in Korea.

Lee H, Min BH, Lee JH, Son HJ, Kim JJ, Rhee JC, Kim S, Rhee PL.

Digestion. 2011;84(2):142-8. doi: 10.1159/000326857. Epub 2011 Apr 27.

PMID:
21525769

Supplemental Content

Support Center